SCHOTT Pharma AG & Co. KGaA Stock Deutsche Boerse AG
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.2 EUR | +0.28% | +0.14% | -15.98% |
06-05 | SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion | CI |
05-28 | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
Sales 2024 * | 976M 1.06B 1.45B | Sales 2025 * | 1.1B 1.2B 1.64B | Capitalization | 4.24B 4.62B 6.32B |
---|---|---|---|---|---|
Net income 2024 * | 144M 157M 214M | Net income 2025 * | 167M 182M 249M | EV / Sales 2024 * | 4.55 x |
Net Debt 2024 * | 200M 218M 298M | Net Debt 2025 * | 188M 205M 280M | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
29.2
x | P/E ratio 2025 * |
25.6
x | Employees | 4,687 |
Yield 2024 * |
0.55% | Yield 2025 * |
0.65% | Free-Float | 23% |
1 day | +0.28% | ||
1 week | +0.14% | ||
Current month | -3.01% | ||
1 month | -24.47% | ||
3 months | -25.26% | ||
6 months | -2.07% | ||
Current year | -15.98% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 23-04-03 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 23-04-03 |
Chairman | 59 | 23-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 28.4 | +1.00% | 550 |
24-06-05 | 28.12 | -2.63% | 7 |
24-06-04 | 28.88 | -2.76% | 0 |
24-06-03 | 29.7 | +1.43% | 190 |
24-05-31 | 29.28 | +3.24% | 301 |
Delayed Quote Deutsche Boerse AG, June 06, 2024 at 01:31 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.18% | 180B | |
-0.21% | 108B | |
-2.00% | 68.29B | |
-6.25% | 46.96B | |
+14.44% | 45.64B | |
+7.77% | 42.41B | |
+19.61% | 31.01B | |
+16.55% | 25.51B | |
-7.11% | 23.17B |
- Stock Market
- Equities
- 1SXP Stock
- 1SXP Stock